Part 3/7:
Neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and ALS (Amyotrophic Lateral Sclerosis) remain some of the most challenging conditions in medicine today. The administration emphasizes their commitment to finding targeted and effective treatments for these debilitating illnesses. The goal is to see innovative therapies reach the market that can slow or halt disease progression, ultimately offering hope to millions affected by these conditions.